Global Mumps Virus Vaccine Live Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Mumps Virus Vaccine Live Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Single-dose Medication
- 1.3.3 Combination Medication
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Mumps Virus Vaccine Live Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Children
- 1.4.3 Adults
- 1.5 Global Mumps Virus Vaccine Live Market Size & Forecast
- 1.5.1 Global Mumps Virus Vaccine Live Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Mumps Virus Vaccine Live Sales Quantity (2021-2032)
- 1.5.3 Global Mumps Virus Vaccine Live Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Merck
- 2.1.1 Merck Details
- 2.1.2 Merck Major Business
- 2.1.3 Merck Mumps Virus Vaccine Live Product and Services
- 2.1.4 Merck Mumps Virus Vaccine Live Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Merck Recent Developments/Updates
- 2.2 GSK
- 2.2.1 GSK Details
- 2.2.2 GSK Major Business
- 2.2.3 GSK Mumps Virus Vaccine Live Product and Services
- 2.2.4 GSK Mumps Virus Vaccine Live Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 GSK Recent Developments/Updates
- 2.3 SINOVAC
- 2.3.1 SINOVAC Details
- 2.3.2 SINOVAC Major Business
- 2.3.3 SINOVAC Mumps Virus Vaccine Live Product and Services
- 2.3.4 SINOVAC Mumps Virus Vaccine Live Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 SINOVAC Recent Developments/Updates
- 2.4 AIM Vaccine
- 2.4.1 AIM Vaccine Details
- 2.4.2 AIM Vaccine Major Business
- 2.4.3 AIM Vaccine Mumps Virus Vaccine Live Product and Services
- 2.4.4 AIM Vaccine Mumps Virus Vaccine Live Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 AIM Vaccine Recent Developments/Updates
- 2.5 Shanghai Institute of Biological Products
- 2.5.1 Shanghai Institute of Biological Products Details
- 2.5.2 Shanghai Institute of Biological Products Major Business
- 2.5.3 Shanghai Institute of Biological Products Mumps Virus Vaccine Live Product and Services
- 2.5.4 Shanghai Institute of Biological Products Mumps Virus Vaccine Live Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Shanghai Institute of Biological Products Recent Developments/Updates
3 Competitive Environment: Mumps Virus Vaccine Live by Manufacturer
- 3.1 Global Mumps Virus Vaccine Live Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Mumps Virus Vaccine Live Revenue by Manufacturer (2021-2026)
- 3.3 Global Mumps Virus Vaccine Live Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Mumps Virus Vaccine Live by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Mumps Virus Vaccine Live Manufacturer Market Share in 2025
- 3.4.3 Top 6 Mumps Virus Vaccine Live Manufacturer Market Share in 2025
- 3.5 Mumps Virus Vaccine Live Market: Overall Company Footprint Analysis
- 3.5.1 Mumps Virus Vaccine Live Market: Region Footprint
- 3.5.2 Mumps Virus Vaccine Live Market: Company Product Type Footprint
- 3.5.3 Mumps Virus Vaccine Live Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Mumps Virus Vaccine Live Market Size by Region
- 4.1.1 Global Mumps Virus Vaccine Live Sales Quantity by Region (2021-2032)
- 4.1.2 Global Mumps Virus Vaccine Live Consumption Value by Region (2021-2032)
- 4.1.3 Global Mumps Virus Vaccine Live Average Price by Region (2021-2032)
- 4.2 North America Mumps Virus Vaccine Live Consumption Value (2021-2032)
- 4.3 Europe Mumps Virus Vaccine Live Consumption Value (2021-2032)
- 4.4 Asia-Pacific Mumps Virus Vaccine Live Consumption Value (2021-2032)
- 4.5 South America Mumps Virus Vaccine Live Consumption Value (2021-2032)
- 4.6 Middle East & Africa Mumps Virus Vaccine Live Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Mumps Virus Vaccine Live Sales Quantity by Type (2021-2032)
- 5.2 Global Mumps Virus Vaccine Live Consumption Value by Type (2021-2032)
- 5.3 Global Mumps Virus Vaccine Live Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Mumps Virus Vaccine Live Sales Quantity by Application (2021-2032)
- 6.2 Global Mumps Virus Vaccine Live Consumption Value by Application (2021-2032)
- 6.3 Global Mumps Virus Vaccine Live Average Price by Application (2021-2032)
7 North America
- 7.1 North America Mumps Virus Vaccine Live Sales Quantity by Type (2021-2032)
- 7.2 North America Mumps Virus Vaccine Live Sales Quantity by Application (2021-2032)
- 7.3 North America Mumps Virus Vaccine Live Market Size by Country
- 7.3.1 North America Mumps Virus Vaccine Live Sales Quantity by Country (2021-2032)
- 7.3.2 North America Mumps Virus Vaccine Live Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Mumps Virus Vaccine Live Sales Quantity by Type (2021-2032)
- 8.2 Europe Mumps Virus Vaccine Live Sales Quantity by Application (2021-2032)
- 8.3 Europe Mumps Virus Vaccine Live Market Size by Country
- 8.3.1 Europe Mumps Virus Vaccine Live Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Mumps Virus Vaccine Live Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Mumps Virus Vaccine Live Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Mumps Virus Vaccine Live Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Mumps Virus Vaccine Live Market Size by Region
- 9.3.1 Asia-Pacific Mumps Virus Vaccine Live Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Mumps Virus Vaccine Live Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Mumps Virus Vaccine Live Sales Quantity by Type (2021-2032)
- 10.2 South America Mumps Virus Vaccine Live Sales Quantity by Application (2021-2032)
- 10.3 South America Mumps Virus Vaccine Live Market Size by Country
- 10.3.1 South America Mumps Virus Vaccine Live Sales Quantity by Country (2021-2032)
- 10.3.2 South America Mumps Virus Vaccine Live Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Mumps Virus Vaccine Live Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Mumps Virus Vaccine Live Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Mumps Virus Vaccine Live Market Size by Country
- 11.3.1 Middle East & Africa Mumps Virus Vaccine Live Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Mumps Virus Vaccine Live Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Mumps Virus Vaccine Live Market Drivers
- 12.2 Mumps Virus Vaccine Live Market Restraints
- 12.3 Mumps Virus Vaccine Live Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Mumps Virus Vaccine Live and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Mumps Virus Vaccine Live
- 13.3 Mumps Virus Vaccine Live Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Mumps Virus Vaccine Live Typical Distributors
- 14.3 Mumps Virus Vaccine Live Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Mumps Virus Vaccine Live market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
The mumps virus vaccine live is a live virus vaccine prepared using attenuated technology. It is used to prevent mumps, an acute respiratory infectious disease caused by the mumps virus. The virus contained in the vaccine has been weakened and will not cause disease, but can stimulate the body to produce immunity. After vaccination, it can effectively improve the resistance of children and adolescents to mumps and reduce the incidence rate. In my country, it is generally recommended that children aged 1-15 and adults who have not had mumps should be vaccinated with this vaccine.
This report is a detailed and comprehensive analysis for global Mumps Virus Vaccine Live market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Mumps Virus Vaccine Live market size and forecasts, in consumption value ($ Million), sales quantity (KG), and average selling prices (US$/G), 2021-2032
Global Mumps Virus Vaccine Live market size and forecasts by region and country, in consumption value ($ Million), sales quantity (KG), and average selling prices (US$/G), 2021-2032
Global Mumps Virus Vaccine Live market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (KG), and average selling prices (US$/G), 2021-2032
Global Mumps Virus Vaccine Live market shares of main players, shipments in revenue ($ Million), sales quantity (KG), and ASP (US$/G), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Mumps Virus Vaccine Live
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Mumps Virus Vaccine Live market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, GSK, SINOVAC, AIM Vaccine, Shanghai Institute of Biological Products, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Mumps Virus Vaccine Live market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Single-dose Medication
Combination Medication
Market segment by Application
Children
Adults
Major players covered
Merck
GSK
SINOVAC
AIM Vaccine
Shanghai Institute of Biological Products
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Mumps Virus Vaccine Live product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Mumps Virus Vaccine Live, with price, sales quantity, revenue, and global market share of Mumps Virus Vaccine Live from 2021 to 2026.
Chapter 3, the Mumps Virus Vaccine Live competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Mumps Virus Vaccine Live breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Mumps Virus Vaccine Live market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Mumps Virus Vaccine Live.
Chapter 14 and 15, to describe Mumps Virus Vaccine Live sales channel, distributors, customers, research findings and conclusion.